Patents by Inventor James A. Longstreth

James A. Longstreth has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240156836
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: August 17, 2023
    Publication date: May 16, 2024
    Inventors: Robert E. Dudley, Theodore Danoff, James A. Longstreth
  • Publication number: 20220088034
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: April 20, 2021
    Publication date: March 24, 2022
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20210220374
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: August 24, 2020
    Publication date: July 22, 2021
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES, James A. LONGSTRETH
  • Publication number: 20200197412
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20200197413
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone undecanoate are provided.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 25, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20200054648
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: March 21, 2019
    Publication date: February 20, 2020
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES, James A. LONGSTRETH
  • Publication number: 20200038411
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum plasma testosterone levels over an extended period.
    Type: Application
    Filed: March 7, 2019
    Publication date: February 6, 2020
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20180333423
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum plasma testosterone levels over an extended period.
    Type: Application
    Filed: May 18, 2018
    Publication date: November 22, 2018
    Inventors: Robert E. DUDLEY, Theodore DANOFF, James A. LONGSTRETH
  • Publication number: 20170246184
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed to provide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: March 14, 2017
    Publication date: August 31, 2017
    Inventors: Robert E. DUDLEY, Panayiotis P. CONSTANTINIDES, James A. LONGSTRETH
  • Publication number: 20140303129
    Abstract: Methods of treating a testosterone deficiency or its symptoms with a pharmaceutical formulation of testosterone esters are provided. The methods are designed toprovide optimum serum testosterone levels over an extended period.
    Type: Application
    Filed: March 17, 2014
    Publication date: October 9, 2014
    Applicant: Clarus Therapeutics, Inc.
    Inventors: Robert E. Dudley, Panayiotis P. Constantinides, James A. Longstreth
  • Patent number: 5955500
    Abstract: Pharmaceutical compositions containing non-racemic mixtures of verapamil are described, as well as a process of making pharmaceutical compositions containing unequal amounts of R- and S-verapamil.A process for customizing a pharmaceutical composition containing R-verapamil and S-verapamil to optimize a selected pharmaceutical activity comprises selecting a pharmaceutical activity possessed by R-verapamil or S-verapamil, alone or in combination, and then determining a target plasma level for R-verapamil and S-verapamil to achieve that activity is also described. A dosage form for administering the drug is selected. Based on dosage form, one determines the relative amounts of R- and S-verapamil to incorporate into the dosage form to achieve the targeted plasma levels. The dosage form can then be formulated.
    Type: Grant
    Filed: May 23, 1997
    Date of Patent: September 21, 1999
    Assignee: G. D. Searle & Co.
    Inventors: James A. Longstreth, Jamali Fakhreddin